| Nome |
# |
|
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors, file e4233f18-9584-2860-e053-6605fe0a460a
|
87
|
|
null, file e4233f17-03df-2860-e053-6605fe0a460a
|
84
|
|
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling., file e4233f14-fc88-2860-e053-6605fe0a460a
|
64
|
|
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates, file e4233f17-0528-2860-e053-6605fe0a460a
|
34
|
|
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody., file e4233f16-3733-2860-e053-6605fe0a460a
|
29
|
|
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma, file e4233f16-e783-2860-e053-6605fe0a460a
|
25
|
|
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma, file e4233f17-7c4c-2860-e053-6605fe0a460a
|
23
|
|
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET, file 3b7de6c7-ad99-4c24-a0bc-07418603358a
|
21
|
|
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma, file e4233f17-8230-2860-e053-6605fe0a460a
|
21
|
|
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications, file ad221ea8-7481-49fb-87f1-0833300bc915
|
17
|
|
Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting, file e4233f17-8622-2860-e053-6605fe0a460a
|
17
|
|
Prognostic relevance of LGALS3BP in human colorectal carcinoma, file e4233f17-ee8a-2860-e053-6605fe0a460a
|
15
|
|
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey, file e4233f15-caa2-2860-e053-6605fe0a460a
|
13
|
|
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma, file e4233f18-51bf-2860-e053-6605fe0a460a
|
13
|
|
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma, file b5a2d813-9694-474b-b6b6-8c6087c42654
|
12
|
|
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants, file e4233f17-ee87-2860-e053-6605fe0a460a
|
12
|
|
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer, file e4233f16-dfd1-2860-e053-6605fe0a460a
|
11
|
|
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer, file e4233f17-e4be-2860-e053-6605fe0a460a
|
11
|
|
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file eefa9c0c-0a62-48a3-b14b-64ceadad9992
|
11
|
|
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study, file cbf6c109-9e4b-4d70-a8a0-4fbf9b6c2a48
|
9
|
|
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer, file e4233f15-0a20-2860-e053-6605fe0a460a
|
8
|
|
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma, file 964f00b4-a892-436e-b396-946d6d41f49f
|
7
|
|
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target, file b81e5c5f-a118-4da4-a6b3-237f50c2d07c
|
5
|
|
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer, file e4233f14-f164-2860-e053-6605fe0a460a
|
5
|
|
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer, file 2b4ff7e3-523a-48cc-81af-781e794797b9
|
4
|
|
Prognostic value of gender and primary tumor location in metastatic colon cancer, file df8f4303-0b81-4032-a91d-8f4e51621185
|
4
|
|
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer., file e4233f18-4a50-2860-e053-6605fe0a460a
|
4
|
|
Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed., file 30d507c3-c0e8-4db1-a4ac-2bc94b34988c
|
3
|
|
Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum., file 3c63aafc-58b3-4acc-9cce-e2cf6e3b353e
|
3
|
|
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors, file e4233f15-00ab-2860-e053-6605fe0a460a
|
3
|
|
New Targets for Therapy in Pancreatic Cancer, file e4233f15-00ac-2860-e053-6605fe0a460a
|
3
|
|
Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice., file 48c9f32c-b00e-48ee-9e86-ae9fe385fb02
|
2
|
|
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target, file 7c19329b-fd7d-4917-a573-5a2064ea8924
|
2
|
|
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides., file e4233f14-edfc-2860-e053-6605fe0a460a
|
2
|
|
90K (Mac-2 BP) and galectins in tumor progression and metastasis., file e4233f14-ee19-2860-e053-6605fe0a460a
|
2
|
|
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin., file e4233f14-ee56-2860-e053-6605fe0a460a
|
2
|
|
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects., file e4233f14-f1a6-2860-e053-6605fe0a460a
|
2
|
|
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer., file e4233f14-f8e5-2860-e053-6605fe0a460a
|
2
|
|
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer, file e4233f15-6e57-2860-e053-6605fe0a460a
|
2
|
|
ERBB3 BINDING ANTIBODY, file e4233f16-d5ab-2860-e053-6605fe0a460a
|
2
|
|
Novel inhibitors of pvhl-elongin c binding, file e4233f17-20b2-2860-e053-6605fe0a460a
|
2
|
|
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer, file 45d64c2d-1c74-44c1-bf85-02f31e7eafbd
|
1
|
|
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival, file e4233f14-edac-2860-e053-6605fe0a460a
|
1
|
|
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer, file e4233f14-f0fb-2860-e053-6605fe0a460a
|
1
|
|
Phospholipase Cgamma1 is required for metastasis development and progression, file e4233f14-f102-2860-e053-6605fe0a460a
|
1
|
|
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein., file e4233f14-f190-2860-e053-6605fe0a460a
|
1
|
|
Unknown primary tumors, file e4233f14-f862-2860-e053-6605fe0a460a
|
1
|
|
Tyrosine kinase inhibitors, file e4233f14-fcb1-2860-e053-6605fe0a460a
|
1
|
|
Epirubicin plus low-dose trastuzumab in HER2 positivemetastatic breast cancer, file e4233f15-013d-2860-e053-6605fe0a460a
|
1
|
|
The use of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy(HIPEC) in patients undergoing cytoreductive surgery (CS) for peritoneal carcinomatosis ofovarian origin, file e4233f15-0140-2860-e053-6605fe0a460a
|
1
|
|
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice., file e4233f15-0176-2860-e053-6605fe0a460a
|
1
|
|
Tumor-derived microvesicles: The metastasomes., file e4233f15-079e-2860-e053-6605fe0a460a
|
1
|
|
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study, file e4233f18-3b33-2860-e053-6605fe0a460a
|
1
|
| Totale |
610 |